For Patients For Medical Professionals

HELPLINE 1-800-465-4837
Mon-Fri 9am – 5pm EST

Texas State Resource Center

State Resources

Our Mission

ALF promotes education, advocacy, support services and research for the prevention, treatment and cure of liver disease. ALF Texas provides a wide variety of these services including information and referral, education programs, support groups, exciting fundraising events, and an array of volunteer opportunities.

Jackie Dominguez
Senior National Director, Engagement

For help with issues related to liver disease, please contact our Help Center by using the Live Chat feature at the bottom of your browser window or call us at (800) 465-4837 Monday through Friday 9 am to 5 pm Eastern Time or by email at

Support groups provide a place for individuals affected by a similar condition or circumstance to provide and receive support and share their experiences.

Not all support groups are facilitated by a medical professional. Some support groups are facilitated by 3rd party organizations and individuals in this region.

ALF also has identified virtual online support groups you can take advantage of by visiting this page.


Austin – Eastside

Carver Library
1161 Angelina St.
Austin, TX 78702

Meets: Meet every 3rd Wednesday at 6:30 p.m.


Bryan – College Station

St. Joseph Hospital
Education Annex
3030 E. 29th St., Suite 100
Bryan, TX

Meets: Meet the 1st Wednesday at 6:30 p.m.


Organ Transplant Support Group

Methodist Dallas Medical Center
1441 N Beckley
Service Building – Room A-1
Dallas, TX 75203

Organ transplants can affect a person’s body and life in many ways. Adjusting to these changes is often easier with the help of people who have had similar experiences which is why the Methodist Dallas Transplant Institute hosts a transplant support group.

Meets: 6:00-8:00pm
Phone: 214-947-4414

El Paso

Support Group

St. Clement’s Episcopal Church
810 N. Campbell St.
El Paso, TX 79902

Meets: Meet the last Thursday at 6:30 p.m.

Fort Worth

Baylor Scott & White – All Saints Medical Center Liver Disease Support Group

Carter Rehabilitation and Fitness Center
Education Room
1350 All Saints Avenue
Ft. Worth, TX 76104

This group will provide education and support for those diagnosed with liver disease. Presenters will provide attendees with actionable tips and recommendations that can be implemented to improve liver health.

Meets: Meets on the third Thursday of each month from 6:00-7:30 p.m.

Online Support Group

This is an online support group that meets every Friday periodically throughout the day Hep C Warriors Friday Forum Support Group


Methodist Hospital – Willowbrook

18220 Tomball Parkway, Hwy. 249
Room C, First Floor
Houston, TX 77030

Meets: Meet the 2nd Tuesday at 7:00 p.m.

St. Luke’s Health System Support Groups

St. Luke’s Liver Health Outreach
6620 Main Street, Suite 1505
Houston, TX 77030

You are not alone — an estimated 4 million people are living with chronic hepatitis C.

Phone: (832) 355-5119 / (800) 72-LIVER

Texas Children’s Hospital

Texas Children’s Liver Center’s support group is a great way to meet other parents who have children with liver disease. We provide mutual support and share resources related to raising children who are especially special.

You can get to know parents whose children have the same condition as yours, live in the same part of town, or have a child the same age. Parents network through phone, e-mail and monthly meetings. These meetings provide a forum to solve problems, complain and laugh with other people who “get it.” Activities are open to families regardless of where their child is treated. Occasional guest speakers cover topics such as developments in research, helping your child through the school system and maintaining normal family life. English-Spanish translators attend each meeting. For more information, e-mail


The Methodist Hospital Liver Transplant Support Group

The Methodist Hospital
Dunn Tower – Sabine Room
6565 Fannin Street
Houston, TX 77030

All liver patients and their families are invited! A light supper is served.

Meets: Meets 1st and 3rd Thursday from 4:00-5:00 p.m.
Phone: 713-441-7788

Contact John Ontiveros for more information.


Scott & White Memorial Hospital

Conference Center, Room 212B
2400 South 31st St.
Temple, TX 76504

Meets: Meet the 2nd Wednesday at 6:00 p.m.

Find a Clinical Trial anywhere…

Participating in a clinical trial is a great way to contribute to curing, preventing and treating liver disease and its complications. Start your search here to find clinical trials that need people like you.

Conatus 14

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects with Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension

Contact Stevan Gonzalez, MD for more information.

Cystatin C

Assessment of Renal Function in Cirrhotic Patients – A Comparison of Cystatin C and Creatinine Based Calculations to 125I-iothalmate

Contact Stevan Gonzalez, MD for more information.


A Multicenter, Randomized, Double Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Non-Alcoholic Steatohepatitis (NASH) and fibrosis”

Contact Stevan Gonzalez, MD for more information.

Intercept 747-302

A Phase 3b, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Subjects with Primary Biliary Cirrhosis

Contact Manjushree Gautam, MD for more information.

Intercept NASH 747-303

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis

Contact Apurva Modi, MD for more information.


A Multicenter, Randomized, Double Blind, Placebo-Controlled Phase III Study to Confirm the Efficacy and Safety of Terlipressin in Patients with Hepatorenal Syndrome Type 1 (The CONFIRM Study)

Contact Stevan Gonzalez, MD for more information.


A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)

Contact Apurva Modi, MD for more information.

In addition to the resources listed above in your state or district, ALF provides these resources that are available no matter where you are. Explore them now…

Last Updated on December 28, 2021


Share this page